Schedule 13G ownership disclosure
Mirati Therapeutics Inc
Security class unavailable · CUSIP: 60468T105
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.1500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-17-000226
- Form type
- SC 13G
- Filer
- Broadfin Capital, LLC
- CIK
- CIK 1511901
- Filed
- Jan 09, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership